Plain-English translation of NCT06458075 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing whether training doctors to communicate better about lupus medications can help patients take them more consistently and improve health outcomes. Many lupus patients, especially Black patients, struggle with taking their medications regularly—not always because they don't want to, but sometimes because of concerns, beliefs, or trust issues with their care team. Researchers believe that better conversations between doctors and patients can build trust and help more people stay on their medications.
People with lupus need to take their medications regularly to prevent serious organ damage and stay healthy, but many patients don't take them as prescribed. Black patients with lupus face even bigger challenges with medication adherence, and doctors often don't have good training in how to talk with patients about these struggles. This study exists to teach doctors how to have these difficult conversations in a more understanding, collaborative way.
You likely qualify if…
You likely don't qualify if…
If you join this study, you would continue seeing your regular lupus doctor at your usual appointments. Your doctor may have received special training on how to discuss your medications with you in a new way—focusing on understanding any challenges you face and building trust together. During your visits, the research team may record conversations (with your permission) and track information about your medication refills from your pharmacy records to see if the new approach helps you take your medications more consistently.
AI-generated summary from trial data · Aug 27, 2026 · Not medical advice
United States